Reddy part of breast cancer chemo study

In Feature by admin

Dr. Reddy

Dr. Reddy

MSSC member Dr. Pavan Reddy, an oncologist/hematologist with Cancer Center of Kansas, is among authors of a study that determined that many women diagnosed with early stage breast cancer do not need chemotherapy.

The study of more than 10,000 women found that those who had midrange scores on a 21-gene test, the Oncotype DX Breast Cancer Assay, had similar outcomes with endocrine therapy, including tamoxifen and related medicines, as they did with a combination of endocrine therapy and chemotherapy. Women in the category had recurrent scores of 11 to 25 and their cancer had not spread to lymph nodes, among other factors. The study appeared in the New England Journal of Medicine and can be found at www.nejm.org/doi/full/10.1056/NEJMoa1804710.